myloidosis, first reported in 1856, is a disease caused by extracellular deposition of fibrous protein in various tissues and organs. The disease mainly affects the kidneys, heart, and gastrointestinal tract. However, omentum and peritoneum are rarely affected. Amyloidosis develops in approximately 12-15% of multiple myeloma (MM) patients. 1 The fibrous protein is produced by the myeloma cells.
1,2 Although MM-associated amyloidosis has complex clinical findings, the symptoms are vague, which may lead to the misdiagnosis and delayed diagnosis of the disease. A definitive diagnosis of amyloidosis requires positive amyloid tissue staining, proof of plasma cell disorder, and amyloid linked organ dysfunction. 3 In the present study, a patient having omental mass and peritoneal thickness with abdominal ascites and elevated CA 125 levels, mimicking peritoneal carcinomatosis but later diagnosed as MM, is being reported.
CASE REPORT
A 61-year-old woman was admitted to the gynecologic oncology department of Gaziantep University with abdominal distention, dyspnea, and elevated Canser Antigen 125 (CA125) levels as well as a history of mild hypertrophic cardiomyopathy. Her computed tomography revealed diffuse omental thickening (caking), unilateral severe pleural effusion, and abdominal ascites ( Figure 1 clear and yellow transudative fluid and reactive mesothelial cells in the ascites ; however, there were no tumor cells. An elevated level of CA125 was found in control value (447 U/mL; normal <35 U/mL). CEA and CA19-9 levels were normal. All these preoperative findings were suggestive of peritoneal carcinomatosis. The patient underwent an exploratory laparotomy. Diffuse thickened peritoneum and omental cake with multiple solid-crispy fields were observed (Figure 2 ). Both ovaries, fallopian tubes, and the uterus were normal in size and appearance with no solid or cystic mass at the adnexa of the uterus. A total omentectomy was performed and multiple peritoneal biopsies were taken. The biopsy samples evaluated by frozen section procedure were found to be benign. We aspirated approximately 2 L of ascites during the operation. Macroscopic examination of the omentum and peritoneum revealed nothing prominent. Hematoxylin and eosin staining showed amorphous, homogenous eosinophilic material around the adipose tissue and the vessel wall (Figure 3) . The Congo red stain highlighted the amorphous material (Figure 4 green birefringence was observed under polarized light. The immunohistochemical test confirmed this amyloid as primary type amyloid (AL). Bone marrow biopsy and bone marrow aspiration were performed and monoclonal plasma cell (Lambda positive) infiltrationwith MM was reported by the pathologist. Consequently, the patient was diagnosed with secondary omental and peritoneal amyloidosis due to MM. The patient was admitted to the medical oncology department of Gaziantep University for the treatment and follow-up. The VCD (bortezomib/cyclophosphamide/dexamethasone) treatment protocol was planned for the patient with her consent.
This study eas carried out eith the patient's approval.
DISCUSSION
Amyloidosis is a heterogeneous group of diseases caused by extracellular deposition of an insoluble protein in various organs and tissues. Amyloid is a protein that gets deposited in several organs and tissues including kidneys, heart, liver, lungs, and skin. It was first described by Wilksin in 1856. The three main types of amyloidosis are primary (AL), secondary (AA), and familial (ATTR) amyloidosis. All these types of amyloidosis differ in pathogenesis, clinical symptoms, and prognoses. Primary amyloidosis is associated with plasma cell dyscrasia and 30% of the cases are asymptomatic. 1, 4 Multiple Myeloma (MM) is the cause of approximately 20% of amyloidosis. 5 Unusual symptoms and findings may lead to misdiagnosis or delayed diagnosis. We report a patient with MM-associated primary amyloidosis whose initial symptoms were abdominal ascites and elevated CA125 level closely mimicking peritoneal carcinomatosis. The first case related to the peritoneal amyloid formation with ascites was reported in 1985. 6 Very few cases that mimicked peritoneal carcinomatosis of omental amyloidosis have been reported. The final diagnosis is carried out pathologically with electron microscopy. 4 Omental biopsy could be performed;
however, in our case, explorative laparotomy was done due to a high suspicion of malignancy. Exploratory laparotomy revealed diffuse infiltration of the omentum related with transudative ascitic fluid. Ascites with primary amyloidosis may result from nephrotic syndrome, congestive heart failure, or hepatocellular disease. However, our patient demonstrated normal renal and liver function with mild hypertrophic cardiomyopathy. The ascites is a consequence of omental amyloid infiltration. The mesothelial cells increase level of CA125. 7 Amyloid depositions can mimic both neoplastic and nonneoplastic conditions. Therefore, omental amyloidosis should be considered as a possible reason for omental mass with abdominal ascites, pleural effusion, and elevated CA125 level. Primary amyloidosis can be idiopathic or associated with MM. Thus, screening tests, differential diagnosis, and evaluation of the primary disease in detail are necessary before the treatment. 
